June 22, 2021 — It is no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-19 ...
Wearables
This channel includes news and new technology innovations for wearable cardiac diagnostic systems. These include technologies related to smart phone apps, wearable monitors, consumer-grade wearables and medical grade FDA cleared wearables. A good overview on the future of these technologies can be found in this article.
June 16, 2021 — Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated ...
June 3, 2020 — GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...
Technology-enabled “Insourcing” approach to cardiac arrhythmia diagnosis provides patient and provider benefits The ...
May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — ...
May 10, 2021 – Today, the Consumer Technology Association (CTA) announced it is collaborating with the American College ...
May 6, 2021 — The wearable cardiac devices market is set to grow from its current market was valued at more than $1.2 ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...
February 23, 2021 — Remote cardiac monitoring vendor RhythMedix released its next-generation RhythmStar wearable device ...
There is a lot of talk about health disparities between the insured vs. uninsured, low-income vs. higher-income, rural ...
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current ...
February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated ele ...
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive a ...
Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking VITAL ...
November 16, 2020 — The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study ...
June 22, 2021